Samsung SDS hosts 'RX ART 2026' in US to validate robot transformation technologies

Samsung SDS has moved decisively to strengthen synergies around robot transformation, or RX, bringing together Samsung affiliates and global robotics companies to identify ways to validate and deploy the technology on factory floors.

Samsung SDS announced Thursday that it held RX ART 2026 in Mountain View, California, from Monday to Tuesday. Senior executives and leaders responsible for robotics at major Samsung affiliates attended to discuss collaboration and identify shared challenges.

Samsung SDS worked with its affiliates to identify robot use cases for industrial settings, then proactively validated those cases with global physical AI companies including Walden Robotics and RoboForce.

The event went beyond simple technology demonstrations: participants gathered data essential for AI training based on real-world factory challenges and rigorously assessed the feasibility of deploying robots in those environments. Samsung SDS said the process allowed it to map out the optimal approach for introducing RX on industrial sites.

In one area, Samsung SDS used general-purpose robots from Walden Robotics to replicate a range of manual tasks required at manufacturing sites — including parts handling and consumable replacement — at facilities such as Samsung Electro-Mechanics and Semes, and assessed their readiness for actual deployment.

At shipbuilding and plant sites operated by Samsung Heavy Industries and Samsung E&A, the company verified RoboForce's physical AI-based robotic labor technology in unstructured, rugged outdoor environments, confirming the potential for robot automation in such conditions.

In addition, Samsung SDS demonstrated that precision-manipulation AI technology from robotics startup Company G was effective in the high-precision manufacturing and equipment environments found at operations such as Samsung Display, offering a glimpse into the potential for automating delicate processes.

Samsung SDS plans to rapidly translate the technical possibilities and optimal deployment approaches confirmed through RX ART 2026 into on-site pilot programs at affiliate facilities, and intends to expand validated robot use cases across a broad range of operations.

"This RX ART was a forum where Samsung affiliates with different manufacturing environments could experience the technology together and share their challenges," said Ahn Dae-jung, head of the digital factory division at Samsung SDS. "Samsung SDS will continue to expand strategic cooperation with global physical AI robotics companies and actively support Samsung affiliates in advancing their manufacturing RX initiatives."